Infections following hematopoietic stem cell transplantation

被引:46
作者
Leather, HL
Wingard, JR
机构
[1] Univ Florida, Coll Med, Dept Med, JHMHC, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Pharm, Dept Pharm, Gainesville, FL 32610 USA
[3] Univ Florida, Bone Marrow Transplant Program, Gainesville, FL USA
关键词
D O I
10.1016/S0891-5520(05)70157-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infections in recipients of hematopoietic stem cell transplantation (HSCT) continue to pose a major problem to the transplant and infectious disease community alike. Strategies employed to prevent bacterial, fungal, and viral infections, as well as treatment strategies once infection is established, is discussed. Included in the article are the recommendations of the Centers for Disease Control/Infectious Diseases Society of America and the American Society of Blood and Marrow Transplantation for the prevention of opportunistic infections in HSCT recipients, along with an evidence-based grading of both the strength and quality of each recommendation.
引用
收藏
页码:483 / +
页数:39
相关论文
共 226 条
[31]   CYTOMEGALOVIRUS DNA DETECTION IN SERA FROM PATIENTS WITH ACTIVE CYTOMEGALOVIRUS INFECTIONS [J].
BRYTTING, M ;
XU, WM ;
WAHREN, B ;
SUNDQVIST, VA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) :1937-1941
[32]   LISTERIOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS - INCIDENCE, CLINICAL-FEATURES, AND TREATMENT [J].
CHANG, J ;
POWLES, R ;
MEHTA, J ;
PATON, N ;
TRELEAVEN, J ;
JAMESON, B .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1289-1290
[33]   EPSTEIN-BARR VIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS - EFFECTS OF ANTI-THYMOCYTE GLOBULIN AND INTERFERON [J].
CHEESEMAN, SH ;
HENLE, W ;
RUBIN, RH ;
TOLKOFFRUBIN, NE ;
COSIMI, B ;
CANTELL, K ;
WINKLE, S ;
HERRIN, JT ;
BLACK, PH ;
RUSSELL, PS ;
HIRSCH, MS .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (01) :39-42
[34]   Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir [J].
Chen, FE ;
Liang, RHS ;
Lo, JY ;
Yuen, KY ;
Chan, TK ;
Peiris, M .
BONE MARROW TRANSPLANTATION, 1997, 20 (11) :997-999
[35]   STREPTOCOCCUS-MITIS SEPSIS IN BONE-MARROW TRANSPLANT PATIENTS RECEIVING ORAL ANTIMICROBIAL PROPHYLAXIS [J].
CLASSEN, DC ;
BURKE, JP ;
FORD, CD ;
EVERSHED, S ;
ALOIA, MR ;
WILFAHRT, JK ;
ELLIOTT, JA .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (04) :441-446
[36]   Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer [J].
Cometta, AF ;
Calandra, T ;
Gaya, H ;
Zinner, SH ;
deBock, R ;
DelFavero, A ;
Bucaneve, G ;
Crokaert, F ;
Kern, WV ;
Klastersky, J ;
Langenaeken, J ;
Micozzi, A ;
Padmos, A ;
Paesmans, M ;
Viscoli, C ;
Glauser, MP ;
Martino, P ;
Caballero, D ;
Engelhard, D ;
Shapiro, M ;
Castagnola, E ;
Massimo, L ;
Giacchino, R ;
Sanz, M ;
Gigium, M ;
Carotenuto, M ;
Lopez, A ;
Andrien, JM ;
Paulus, R ;
Martino, B ;
Nobile, F ;
Togni, P ;
Ferster, A ;
Cudillo, L ;
Legrand, JC ;
Dinota, A ;
Cajozzo, A ;
Quintini, G ;
MartinezDalmau, A ;
Nosari, A ;
Bucaneve, GP ;
Cometta, A ;
Galazzo, M ;
Giddey, M ;
Bille, J ;
Blaser, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1108-1115
[37]   Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations [J].
Cone, RW ;
Huang, MLW ;
Corey, L ;
Zeh, J ;
Ashley, R ;
Bowden, R .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (02) :311-318
[38]   Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation [J].
Cook, RC ;
Connors, JM ;
Gascoyne, RD ;
Fradet, G ;
Levy, RD .
LANCET, 1999, 354 (9191) :1698-1699
[39]   Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis [J].
Cruciani, M ;
Rampazzo, R ;
Malena, M ;
Lazzarini, L ;
Todeschini, G ;
Messori, A ;
Concia, E .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :795-805
[40]  
CRUMPACKER C, 1988, REV INFECT DIS, V10, pS538